2024 Lysosomal Disease Summit Abstract Submission

Abstract submission for the 2024 Lysosomal Disease Summit is now open. All abstracts submitted on or before the 14 June, 2024 (23:59 AEST) deadline will be reviewed by the Lysosomal Disease Summit Program Committee for oral and/or poster presentation, offering a unique opportunity for lysosomal disease scientists and professionals to share their innovative ideas and research.

Click here to submit an abstract.

Any time before the deadline you may return to the submission website to make changes to your abstract, or delete the abstract if you no longer want it considered for presentation. AFTER 14 June, 2024, ALL ABSTRACTS ARE CONSIDERED FINAL AND NO CHANGES MAY BE MADE AND ABSTRACTS MAY NOT BE WITHDRAWN.

The first author of the submitted abstract will be notified of acceptance for oral or poster presentation by 1 July, 2024. It is important to note that the primary author is expected to present the abstract / poster at the Summit. Abstracts selected for oral presentation will receive a discounted registration rate.

A limited number of scholarships will be available in 2024. Click here for more information.

2024 Abstract Submissions Categories

The three (3) categories for 2024 abstract submissions are as follows:

  1. Basic or Translational Scientific Research:
    Disease mechanisms, pathology, biomarkers, natural history, etc.
  2. Clinical Applications:
    including clinical trials and outcomes, case reports or case series
  3. Social, Ethical and Legal Issues (SELI)/ Public health and policy:
    Including newborn and population screening, AI, and machine learning

Abstract Requirements

Abstract Length

Abstracts are required to be no more than 500 words in length and may not contain images or figures.

Number of Authors

Abstract submissions may include no more than 25 authors. NO exceptions.

Disclosure Requirements

  • ALL individuals listed as a first author will be required to submit a disclosure prior to the Lysosomal Disease Summit.
  • Once an author finalizes their own disclosure, the same disclosure will be applied to ALL abstracts on which the individual is a listed author.
  • More details will be sent to accepted authors on 1 July, 2024.

First Authors

The first author will be designated to present the work for all submitted abstracts. Please ensure that the first author (first person listed by the submitter) is the person who will be presenting the abstract at the conference. Once submitted, abstracts may be edited or deleted until the deadline of 14 June, 2024 23:59 AEST; after the deadline, all submissions are considered final and may not be edited or withdrawn.

It is the policy of the Lysosomal Disease Summit to publish all abstracts with the list of authors exactly as the abstract was submitted to the Lysosomal Disease Summit. The first author of the submitted abstract will be listed as the presenting author on the Preliminary Program, Agenda, and/or Poster List. First authors cannot be changed once the listings are published or posted.

Abstract Selection

Abstracts will be selected based on scientific merit, originality and relevancy to lysosomal diseases. Selection occurs through a blinded peer review process. Final placement in an oral platform or poster session is subject to the Program Committee’s discretion.

Abstract Assignments

All abstracts submitted prior to the 14 June, 2024 deadline will be reviewed by the Lysosomal Disease Summit Program Committee for oral or poster presentation. The first author of the submitted abstract will be notified of acceptance for oral or poster presentation by 1 July, 2024. Information will also be posted here on the website as soon as it is available.

Meeting Registration

Note: Individuals who submit abstracts are not automatically registered for the Summit. In order to participate in the Summit as an oral or poster presenter, individuals must register for the meeting and also cover the costs of hotel and travel (if travel costs are applicable). Abstracts selected for oral presentation will receive a discounted registration rate of 50%. A non-transferrable discount code will be included with the Abstract Acceptance Letter to oral presenters.

Abstracts must be submitted with the intention that they will be presented if selected.

Technical Support

If you have any questions regarding the content of the abstract, please contact Drew at drew@nullsaterdalen.com

Customer Support
For help with your abstract submission, email cOASIS Technical Support at ldsummit@nullsupport.ctimeetingtech.com or call 0011-1-217-398-1792 (from Australia) for assistance, Monday-Friday, 08:00-17:00 CDT.